A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma.

Ramya RamaswamiThomas S UldrickMark N PolizzottoKathleen M WyvillPriscila GoncalvesAnaida WidellKathryn LurainSeth M SteinbergWilliam Douglas Figg Giovanna Tosato Nazzarena Labo Robert Yarchoan

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)

Pegylated liposomal doxorubicin in combination with bevacizumab has activity in advanced Kaposi sarcoma, but it is unclear whether the combination yields better outcomes than liposomal doxorubicin used alone.

Keyphrases

metastatic colorectal cancer
drug delivery
cancer therapy
combination therapy
randomized controlled trial
type diabetes
clinical trial
adipose tissue
skeletal muscle
weight loss